All News

Although approximately one-third of patients were found to bypass their nearest hospital for breast cancer surgery, the decision to go further occurred more frequently in certain patient populations.

As a survivor of colorectal cancer, I expect my scan to say that I’m 99% cancer-free, but it’s the 1% that worries me.

Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.

Patients with melanoma play a vital role in their own post-surgical care, as one expert from Dana-Farber Cancer Institute explained to CURE®.

When I told people I have follicular lymphoma, the first reaction I got is "At least you got a good cancer.”

The FDA granted a Fast Track Designation to RC88, a novel antibody-drug conjugate, to treat patients with platinum-resistant gynecologic cancers.

Being a self-advocate also means self-care.

Recent research determined that two specific biomarkers may help predict and protect survivors of childhood cancer from heart risks, such as cardiomyopathy.

Nearly 40% of patients who received treatment for cervical cancer were still being prescribed outpatient opioids for pain management six months later, according to recently published study findings.

When it comes to bladder cancer, it’s important to note the differences between muscle-invasive and non-muscle-invasive bladder cancer, as it can affect the staging of the cancer.

This past holiday season made me realize that I feel a strong sense of fulfillment as a cancer survivor and caregiver.

From Michael Strahan announcing his cancer diagnosis to a “Baywatch” star being diagnosed with cancer, here’s what’s happening in the oncology space this week.

A phase 2 trial is evaluating ELI-002 7P, a novel cancer vaccine, for the treatment of patients with KRAS-mutant pancreatic cancer.

2023 brought some disappointing cancer news to me, but 2024, I have faith in you.

Certain groups of patients with breast cancer experienced a decrease in breast cancer-specific mortality after starting cholesterol-lowering drugs.

Today, on what would have been Jimmy's 65th birthday, I choose to celebrate his life rather than dwell on the pain of his loss from cancer.

Award-winning journalist applied the same dedication that served her award-winning reporting in support of her own survival following a diagnosis of stage 4 anaplastic thyroid cancer.

Patients continue to be enrolled in a study evaluating the dual-action androgen receptor inhibitor ONCT-534 for the treatment of patients with advanced prostate cancer who are relapsed or refractory to approved androgen receptor pathway inhibitors (ARPIs).

“When we talk about recurrence of melanoma, we actually worry more about what we cannot see, what's on the inside,” Dr. Justine V. Cohen of the Dana-Farber Cancer Institute told CURE®.

Children with cancer tended to feel less anxiety after undergoing four sessions of creative art therapy, recent research showed.

Here are four things I found to be helpful as a survivor, including showing up for myself.

Cancer is a dark place, but we can bring light to it.

The Food and Drug Administration (FDA) will not be meeting the Jan. 12, 2024 approval deadline for zolbetuximab to treat certain patients with gastric or gastroesophageal junction adenocarcinoma.

The Food and Drug Administration has accepted a supplemental Biologics License Application (sBLA) intended to convert the accelerated approval granted to Tivdak (tisotumab vedotin-tftv) in 2021 to full approval for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after first-line therapy.

Newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia had better outcomes when receiving Scemblix, compared with a different TKI, a study found.

When I received the news of colon cancer, I gained a new perspective on self-love and living life.

A small study of iopofosine I 131 in patients with pretreated Waldenstrom’s macroglobulinemia showed that the disease control rate was 100%.

More facilitation is needed to ensure that clinicians can connect patients with breast cancer to clinical trials they may be eligible for.